Want to join the conversation?
The company ended 3Q15 with total debt of approx. $42.7Bil and equity of $77.5Bil related to $AGN acquisition and previous financing. In 3Q15, the company paid down about $231MM of debt. In Oct. $AGN borrowed $800MM on its revolving credit facility to fund the Kythera acquisition. Leverage ratio is at 3.98 times debt to pro forma adjusted EBITDA.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?